The expression of FAM227A was significantly higher (stratified by Gleason score, pathologic T stage, pathologic N stage, and biochemical recurrence status) in cancer subgroups than in normal tissue subgroup (Pall < 0.05; Supplementary Fig. 6, available online). This evidence concerns the gene FAM227A and cancer.